Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus

Circular RNAs (circRNAs) represent a class of non‐coding RNAs that form covalently closed RNA circles with extensive expression and conservation in mammals. Circular RNAs regulate gene expression through acting as competitive endogenous RNAs (ceRNAs) and modulating gene transcription. Accumulating evidence supports the implication of circRNAs in a variety of human diseases, but studies of circRNA role in systemic lupus erythematosus (SLE) are lacking. The present study measured the circRNA expression profiles in T cells from patients with SLE and healthy controls with human circRNA microarray and identified 127 differentially expressed circRNAs in SLE patients. Down‐regulation of hsa_circ_0045272 in SLE T cells was verified with quantitative PCR. Jurkat cells with stable hsa_circ_0045272 knockdown were generated using specific lentiviral short hairpin RNA for functional studies. Flow cytometric analysis indicated that hsa_circ_0045272 knockdown significantly up‐regulated the early apoptosis of Jurkat cells. Meanwhile, ELISA showed that hsa_circ_0045272 knockdown significantly enhanced interleukin‐2 production of activated Jurkat cells. Then, ceRNAs were predicted for hsa_circ_0045272 and the significant down‐regulation of two mRNAs predicted as ceRNAs, NM_003466 (PAX8) and NM_015177 (DTX4), but not their corresponding proteins, was validated. Furthermore, dual luciferase reporter assay indicated binding of hsa_circ_0045272 with hsa‐miR‐6127. Circular RNA–mRNA co‐expression networks showed the correlation of circRNAs with mRNAs and provided additional clues to circRNA functions. Our study demonstrated dysregulated circRNAs in SLE and revealed the function of hsa_circ_0045272 in negatively regulating apoptosis and interleukin‐2 secretion and its potential mechanism. The implication of hsa_circ_0045272 and other abnormal circRNAs in SLE merits further investigation.

[1]  D. Ye,et al.  Translation of noncoding RNAs: Focus on lncRNAs, pri‐miRNAs, and circRNAs , 2017, Experimental cell research.

[2]  D. Ye,et al.  Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus. , 2017, Cellular immunology.

[3]  Yu Wang,et al.  Circular RNAs expression profiles in human gastric cancer , 2017, Scientific Reports.

[4]  Zhao-You Tang,et al.  Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma , 2017, Scientific Reports.

[5]  Hai-Feng Liang,et al.  Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271. , 2017, American journal of cancer research.

[6]  Dingji Zhu,et al.  Microarray Expression Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients , 2017, Cellular Physiology and Biochemistry.

[7]  C. Qian,et al.  Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression , 2017, Hepatology.

[8]  D. Ye,et al.  Competitive endogenous RNA network: potential implication for systemic lupus erythematosus , 2017, Expert opinion on therapeutic targets.

[9]  N. Rajewsky,et al.  Translation of CircRNAs , 2017, Molecular cell.

[10]  N. Rajewsky,et al.  Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis , 2017, Molecular cell.

[11]  L. Davis,et al.  Pathways leading to an immunological disease: systemic lupus erythematosus , 2017, Rheumatology.

[12]  Lingling Wu,et al.  Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. , 2016, Journal of autoimmunity.

[13]  Kathleen E. Sullivan,et al.  New insights into the immunopathogenesis of systemic lupus erythematosus , 2016, Nature Reviews Rheumatology.

[14]  D. Ye,et al.  Circular RNAs and systemic lupus erythematosus. , 2016, Experimental cell research.

[15]  D. Xie,et al.  Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells , 2016, Journal of Translational Medicine.

[16]  Julia Salzman,et al.  Circular RNA Expression: Its Potential Regulation and Function. , 2016, Trends in genetics : TIG.

[17]  J. Burdette,et al.  Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium , 2016, Oncotarget.

[18]  H. Xie,et al.  Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer , 2016, Oncotarget.

[19]  Lei Liu,et al.  Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. , 2016, Cancer biomarkers : section A of Disease markers.

[20]  D. Ye,et al.  Emerging role of long noncoding RNAs in autoimmune diseases. , 2015, Autoimmunity reviews.

[21]  Huajie Cai,et al.  cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway , 2015, PloS one.

[22]  Petar Glažar,et al.  Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. , 2015, Molecular cell.

[23]  Vaishali R. Moulton,et al.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. , 2015, The Journal of clinical investigation.

[24]  Xiaoyan Mo,et al.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[25]  Yifeng Zhou,et al.  Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway , 2015, Oncotarget.

[26]  G. Shan,et al.  Exon-intron circular RNAs regulate transcription in the nucleus , 2015, Nature Structural &Molecular Biology.

[27]  R. Zeillinger,et al.  Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues , 2015, Scientific Reports.

[28]  Jae-Hoon Chang,et al.  Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation , 2015, Nature Communications.

[29]  N. Rajewsky,et al.  circRNA biogenesis competes with pre-mRNA splicing. , 2014, Molecular cell.

[30]  L. MaroñasJiménez,et al.  Systemic lupus erythematosus , 2014 .

[31]  E. Steichen,et al.  Enhanced activity of Akt in Teff cells from children with lupus nephritis is associated with reduced induction of tumor necrosis factor receptor-associated factor 6 and increased OX40 expression. , 2013, Arthritis and rheumatism.

[32]  Shanshan Zhu,et al.  Circular intronic long noncoding RNAs. , 2013, Molecular cell.

[33]  M. Zannini,et al.  Pax8 has a critical role in epithelial cell survival and proliferation , 2013, Cell Death and Disease.

[34]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[35]  J. Kjems,et al.  Natural RNA circles function as efficient microRNA sponges , 2013, Nature.

[36]  Michael K. Slevin,et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. , 2013, RNA.

[37]  P. Tak,et al.  MicroRNAs—novel regulators of systemic lupus erythematosus pathogenesis , 2012, Nature Reviews Rheumatology.

[38]  Yinyin Li,et al.  NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4 , 2012, Nature Immunology.

[39]  Ferdinando Di Cunto,et al.  Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs , 2011, Cell.

[40]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[41]  D. Bartel,et al.  Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.

[42]  C. Gordon,et al.  Systemic lupus erythematosus: clinical presentations. , 2010, Autoimmunity reviews.

[43]  C. Kallenberg,et al.  Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus , 2010, Arthritis research & therapy.

[44]  G. Tsokos,et al.  T cells as therapeutic targets in SLE , 2010, Nature Reviews Rheumatology.

[45]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[46]  David A. Isenberg,et al.  Mechanisms of Disease Systemic Lupus Erythematosus , 2008 .

[47]  P. Emery,et al.  The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index. , 2007, Arthritis and rheumatism.

[48]  G. Hughes,et al.  Systemic lupus erythematosus , 2001, The Lancet.

[49]  Yvonne Tay,et al.  A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.

[50]  A. Kribben,et al.  CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus , 2006, Clinical and experimental immunology.

[51]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[52]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[53]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[54]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[55]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[56]  W. Emlen,et al.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.

[57]  J. Goust,et al.  Systemic lupus erythematosus. , 1976, Immunology series.